Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CAH Stock Forecast 2025-2026
$205.37
Current Price
$48.79B
Market Cap
Buy 11
Hold 4
Sell 1
Wall St Analyst Ratings
Distance to CAH Price Targets
+13.0%
To High Target of $232.00
+7.1%
To Median Target of $220.00
-18.7%
To Low Target of $167.00
CAH Price Momentum
+0.8%
1 Week Change
+31.9%
1 Month Change
+72.9%
1 Year Change
+73.6%
Year-to-Date Change
-1.4%
From 52W High of $208.32
+79.2%
From 52W Low of $114.60
📊 TOP ANALYST CALLS
Did CAH Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Cardinal Health is one of their latest high-conviction picks.
Latest CAH Stock Price Targets & Analyst Predictions
Based on our analysis of 23 Wall Street analysts, CAH has a bullish consensus with a median price target of $220.00 (ranging from $167.00 to $232.00). The overall analyst rating is Strong Buy (8.5/10). Currently trading at $205.37, the median forecast implies a 7.1% upside. This outlook is supported by 11 Buy, 4 Hold, and 1 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CAH Analyst Ratings
11
Buy
4
Hold
1
Sell
CAH Price Target Range
Low
$167.00
Average
$220.00
High
$232.00
Current: $205.37
Latest CAH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CAH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 5, 2025 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $221.00 |
| Nov 4, 2025 | Mizuho | Steven Valiquette | Outperform | Maintains | $210.00 |
| Nov 3, 2025 | TD Cowen | Charles Rhyee | Buy | Maintains | $225.00 |
| Oct 31, 2025 | UBS | Kevin Caliendo | Buy | Maintains | $220.00 |
| Oct 31, 2025 | Evercore ISI Group | Elizabeth Anderson | Outperform | Maintains | $220.00 |
| Oct 31, 2025 | Citigroup | Daniel Grosslight | Neutral | Maintains | $190.00 |
| Aug 13, 2025 | Evercore ISI Group | Elizabeth Anderson | Outperform | Maintains | $190.00 |
| Aug 13, 2025 | Baird | Eric Coldwell | Outperform | Maintains | $203.00 |
| Aug 13, 2025 | Wells Fargo | Stephen Baxter | Overweight | Maintains | $185.00 |
| Aug 12, 2025 | Leerink Partners | Michael Cherny | Outperform | Maintains | $186.00 |
| Jul 16, 2025 | Morgan Stanley | Erin Wright | Overweight | Maintains | $190.00 |
| Jun 13, 2025 | Morgan Stanley | Erin Wright | Overweight | Maintains | $181.00 |
| Jun 13, 2025 | Citigroup | Daniel Grosslight | Neutral | Maintains | $170.00 |
| Jun 12, 2025 | Evercore ISI Group | Elizabeth Anderson | Outperform | Maintains | $180.00 |
| Jun 10, 2025 | B of A Securities | Michael Cherny | Buy | Maintains | $170.00 |
| Jun 3, 2025 | Wells Fargo | Stephen Baxter | Overweight | Upgrade | $179.00 |
| Jun 2, 2025 | Evercore ISI Group | Outperform | Maintains | $N/A | |
| May 5, 2025 | Morgan Stanley | Erin Wright | Overweight | Maintains | $166.00 |
| May 2, 2025 | Baird | Eric Coldwell | Outperform | Maintains | $170.00 |
| May 2, 2025 | UBS | Kevin Caliendo | Buy | Maintains | $170.00 |
Cardinal Health Inc. (CAH) Competitors
The following stocks are similar to Cardinal Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
CAH
Cardinal Health
mkt cap
48.39B
Cardinal Health Inc. (CAH) Financial Data
Cardinal Health Inc. has a market capitalization of $48.79B with a P/E ratio of 31.1x. The company generates $234.31B in trailing twelve-month revenue with a 0.7% profit margin.
Revenue growth is +22.4% quarter-over-quarter, while maintaining an operating margin of +1.2% and return on equity of -59.3%.
Valuation Metrics
Market Cap
$48.79B
Enterprise Value
$53.13B
P/E Ratio
31.1x
PEG Ratio
2.8x
Price/Sales
0.2x
Growth & Margins
Revenue Growth (YoY)
+22.4%
Gross Margin
+3.6%
Operating Margin
+1.2%
Net Margin
+0.7%
EPS Growth
+8.2%
Financial Health
Cash/Price Ratio
+9.4%
Current Ratio
1.0x
Debt/Equity
-3.3x
ROE
-59.3%
ROA
+3.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Cardinal Health Inc. (CAH) Business Model
About Cardinal Health Inc.
What They Do
Provides end-to-end medical solutions.
Business Model
The company operates a comprehensive healthcare distribution and supply chain management model, serving hospitals, pharmacies, and healthcare providers. It generates revenue primarily through the distribution of pharmaceuticals, medical products, and laboratory supplies, along with offering services like inventory management and logistics optimization.
Additional Information
Based in Dublin, Ohio, Cardinal Health is one of the largest pharmaceutical distributors in the U.S., playing a crucial role in the healthcare sector and enhancing operational efficiency by ensuring the availability of essential drugs and medical supplies.
Company Information
Sector
Healthcare
Industry
Medical Distribution
Employees
53,084
CEO
Mr. Jason M. Hollar
Country
United States
IPO Year
1987
Website
www.cardinalhealth.comCardinal Health Inc. (CAH) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Are You Looking for a Top Momentum Pick? Why Cardinal Health (CAH) is a Great Choice
Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Nov 10, 2025
By Zacks Equity Research
Tale of the Tape
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Nov 07, 2025
By Zacks Equity Research
Tale of the Tape
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Nov 07, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Cardinal Health, Inc. will participate in the UBS Global Healthcare Conference on November 11, 2025, at 8:45 AM EST, featuring executives Matt Sims and Aaron Alt.
Why It Matters
Cardinal Health's participation at the UBS Global Healthcare Conference signals its engagement with investors, potentially influencing market perception and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Cardinal Health (CAH) is being evaluated for its potential as a top stock pick for momentum investors. Further analysis is needed to determine its suitability.
Why It Matters
The inquiry into Cardinal Health's momentum potential signals interest in its stock performance, suggesting possible investment opportunities and volatility that could attract momentum-focused investors.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Wall Street is rebounding amid hopes for a shutdown resolution, with investors focusing on value stocks like LTH, CAH, MCK, and FLS, which have strong interest coverage ratios.
Why It Matters
Wall Street's rebound signals renewed investor confidence, prompting a shift to value stocks like LTH, CAH, MCK, and FLS, indicating potential for stability and returns amid uncertainty.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Wall Street analysts' ratings influence investors' decisions on stocks, impacting prices. However, the actual significance of these recommendations is questioned.
Why It Matters
Wall Street analysts' ratings influence stock prices and investor sentiment, impacting trading decisions and market dynamics, which can lead to increased volatility and shifts in stock valuations.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Zacks emphasizes its Rank system based on earnings estimates and revisions to identify strong stocks, while also monitoring value, growth, and momentum trends.
Why It Matters
The Zacks Rank system highlights stocks with favorable earnings revisions, indicating potential growth, which can lead to better investment choices based on current market trends.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Zacks Style Scores can guide investors in selecting strong, market-beating stocks for their portfolios.
Why It Matters
The Zacks Style Scores can help identify high-potential stocks, aiding investors in making informed decisions to enhance portfolio performance and achieve market outperformance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About CAH Stock
What is Cardinal Health Inc.'s (CAH) stock forecast for 2026?
Based on our analysis of 23 Wall Street analysts, Cardinal Health Inc. (CAH) has a median price target of $220.00. The highest price target is $232.00 and the lowest is $167.00.
Is CAH stock a good investment in 2026?
According to current analyst ratings, CAH has 11 Buy ratings, 4 Hold ratings, and 1 Sell ratings. The stock is currently trading at $205.37. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CAH stock?
Wall Street analysts predict CAH stock could reach $220.00 in the next 12 months. This represents a 7.1% increase from the current price of $205.37. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Cardinal Health Inc.'s business model?
The company operates a comprehensive healthcare distribution and supply chain management model, serving hospitals, pharmacies, and healthcare providers. It generates revenue primarily through the distribution of pharmaceuticals, medical products, and laboratory supplies, along with offering services like inventory management and logistics optimization.
What is the highest forecasted price for CAH Cardinal Health Inc.?
The highest price target for CAH is $232.00 from at , which represents a 13.0% increase from the current price of $205.37.
What is the lowest forecasted price for CAH Cardinal Health Inc.?
The lowest price target for CAH is $167.00 from at , which represents a -18.7% decrease from the current price of $205.37.
What is the overall CAH consensus from analysts for Cardinal Health Inc.?
The overall analyst consensus for CAH is bullish. Out of 23 Wall Street analysts, 11 rate it as Buy, 4 as Hold, and 1 as Sell, with a median price target of $220.00.
How accurate are CAH stock price projections?
Stock price projections, including those for Cardinal Health Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: November 15, 2025 9:08 AM UTC